Lataa...
Modified metformin as a more potent anticancer drug: Mitochondrial inhibition, redox signaling, antiproliferative effects and future EPR studies
Metformin, one of the most widely prescribed antidiabetic drugs in the world is being repurposed as a potential drug in cancer treatment. Epidemiological studies suggest that metformin exerts anticancer effects in diabetic patients with pancreatic cancer. However, at typical antidiabetic doses the b...
Tallennettuna:
| Julkaisussa: | Cell Biochem Biophys |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5680142/ https://ncbi.nlm.nih.gov/pubmed/28429253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12013-017-0796-3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|